IFI30, GBP1 and GBP4 were upregulated 2-8-fold (p < 0.0001) in IFNγ positive tumors vs. IFNγ negative tumors (Figure 6) in each of the six tumor types. This evidence concerns the gene GBP4 and neoplasm.